SCHEDULE OF COMMON STOCK ISSUED AND OUTSTANDING (Details) (Parenthetical) - USD ($) |
1 Months Ended | 6 Months Ended | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
May 08, 2026 |
Jan. 23, 2026 |
May 08, 2026 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
||||||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||
| Common stock, par value | $ 0.06 | $ 0.06 | $ 0.06 | $ 0.001 | $ 0.001 | |||||||||||
| Broker commission | $ 20,960 | $ 2,000 | $ 27,360 | |||||||||||||
| Common stock, shares issued | 1,440,001 | 4,716,000 | 1,440,001 | 114,695,220 | 108,147,731 | |||||||||||
| Weighted average remaining contractual term, Ending balance | 4 years 3 months 18 days | 2 years 8 months 12 days | ||||||||||||||
| Weighted average exercise price | $ 0.13 | $ 0.22 | $ 0.13 | $ 0.22 | ||||||||||||
| Share Price | $ 0.0274 | |||||||||||||||
| Private placement offering | $ 314,533 | |||||||||||||||
| Cash commission | $ 6,400 | |||||||||||||||
| Common Stock [Member] | ||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||
| Share Price | $ 0.053 | $ 0.053 | $ 0.053 | |||||||||||||
| Warrant [Member] | ||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||
| Bonus shares | 106,667 | 349,333 | ||||||||||||||
| Warrants outstanding, number of warrants | 22,375,365 | |||||||||||||||
| Weighted average remaining contractual term, Ending balance | 4 years 3 months 18 days | |||||||||||||||
| Private placement offering | $ 123,486 | |||||||||||||||
| Private Placement [Member] | ||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||
| Private placement offering | $ 241,040 | $ 23,000 | ||||||||||||||
| Share Price | $ 0.040 | [1],[2] | $ 0.031 | [2],[3] | $ 0.040 | [1],[2] | $ 0.0310 | |||||||||
| Private placement offering | $ 73,600 | |||||||||||||||
| Private Placement [Member] | Warrant [Member] | ||||||||||||||||
| Subsidiary, Sale of Stock [Line Items] | ||||||||||||||||
| Warrants outstanding, number of warrants | 1,333,334 | 4,366,667 | 5,700,001 | |||||||||||||
| Weighted average remaining contractual term, Ending balance | 5 years | 5 years | ||||||||||||||
| Weighted average exercise price | $ 0.12 | $ 0.12 | $ 0.12 | |||||||||||||
| ||||||||||||||||